Market Exclusive

Analyst Downgrades – Pfizer (NYSE:PFE) Stock Gets Downgraded By Credit Suisse Group from Outperform to Neutral

Analyst Ratings For Pfizer (NYSE:PFE)

Today, Pfizer (NYSE:PFE) stock was downgraded by Credit Suisse Group from Outperform to Neutral with a price target of $36.00.

There are 1 sell rating, 9 hold ratings, 9 buy ratings on the stock.

The current consensus rating on Pfizer (NYSE:PFE) is Hold (Score: 2.42) with a consensus target price of $38.00 per share, a potential 13.03% upside.

Some recent analyst ratings include

Dividend information for Pfizer (NYSE:PFE)

Pfizer (NYSE:PFE) pays an annual dividend of Community Ranking: with a yield of 3.81% and an average dividend growth of 7.70% based on a 3 Year Average.

Dividend History for Pfizer (NYSE:PFE)

Recent Insider Trading Activity For Pfizer (NYSE:PFE)
Pfizer (NYSE:PFE) has insider ownership of 0.06% and institutional ownership of 69.95%.

Recent Trading Activity for Pfizer (NYSE:PFE)
Shares of Pfizer closed the previous trading session at 33.51 down -0.11 -0.33% with 18,810,217 shares trading hands.

Exit mobile version